IBI-60089
IBI-60089 is IBI’s next product using Verisome® technology to enter human clinical trials. IBI-60089 is a biodegradable product for the delivery of therapeutic levels of latanoprost to the anterior chamber.
IBI-60089 is IBI’s next product using Verisome® technology to enter human clinical trials. IBI-60089 is a biodegradable product for the delivery of therapeutic levels of latanoprost to the anterior chamber.
My Canadian Pharmacy is an informative service. All the information should not be used in the purposes to establish a diagnosis and prescribe a treatment plan. Our company is a vendor, not a drug manufacturer. We cooperate with drug manufacturers who distribute their products to us. We have no relation with Icon Bioscience and Verisome. They move to another domain. We bear no responsibility for any damage brought to your health. All the questions related to the drug quality should be addressed to the drug manufacturer directly.